Quick Answer
Connect Biopharma Holdings Ltd reported Total Revenue of $64.0 thousand for fiscal year 2025.
Connect Biopharma Holdings Ltd Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $64.0K | -99.8% |
| 2024 | $26.03M | — |
| 2023 | $0.00 | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $16.0K | -98.7% | -66.7% |
| June 30, 2025 | $48.0K | -99.8% | -96.1% |
| September 30, 2024 | $1.22M | — | -94.9% |
| June 30, 2024 | $24.12M | — | — |
- Connect Biopharma Holdings Ltd showed a decrease of -99.8% in Total Revenue compared to the prior fiscal year.
- The most recent figure is from Connect Biopharma Holdings Ltd’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: